vsv-zebov
Vaccineexperimental
Clinical trial activity
2 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2014 (NCT02287480)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- EbolavirusImmunity, active
Ebolavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vsv-zebov
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02296983 | Phase 1 | Dec 1, 2014 | Albert Schweitzer Hospital, Philipps University of Marburg, University of Geneva, University of Hamburg, University of Oxford, University of Tuebingen, Wellcome Trust, World Health Organization |
| NCT02287480 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2014 | Albert Schweitzer Hospital, Philipps University of Marburg, University of Geneva, University of Hamburg, University of Tuebingen, Wellcome Trust, World Health Organization |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Albert Schweitzer Hospital | Academic/Hospital | 2 | 0 | 2 | 2014 |
| Philipps University of Marburg | Academic/Hospital | 2 | 0 | 2 | 2014 |
| University of Geneva | Academic/Hospital | 2 | 1 | 2 | 2014 |
| University of Hamburg | Academic/Hospital | 2 | 0 | 2 | 2014 |
| University of Tuebingen | Academic/Hospital | 2 | 0 | 2 | 2014 |
| Wellcome Trust | Academic/Hospital | 2 | 0 | 2 | 2014 |
| World Health Organization | Government | 2 | 0 | 2 | 2014 |
| University of Oxford | Academic/Hospital | 1 | 1 | 1 | 2014 |
8 organizations
Page 1 / 1